Knowledge Resource Center for Ecological Environment in Arid Area
| Preclinical evaluation of immunostimulatory gene therapy for pancreatic cancer | |
| Eriksson;Emma | |
| 出版年 | 2017 |
| 学位授予单位 | Uppsala universitet, Institutionen för immunologi, genetik och patologi, Uppsala |
| 英文摘要 | Pancreatic cancer is characterized by its desmoplastic tumor microenvironment and the infiltration of immunosuppressive cells. It is a devastating disease where most patients are diagnosed at a late stage and the treatment options are few. The development of new treatments is surly needed. One treatment option explored is the use of immunotherapy with the intent to activate the immune system and change the balance from pro-tumor to anti-tumor. This thesis presents the idea of using oncolytic adenoviruses called LOAd-viruses that are armed with immunostimulatory- and microenvironment-modulating transgenes. For effective treatment of pancreatic cancer, the virus needs to be able to be given in addition to standard therapy, the chemotherapy gemcitabine. In paper I, the immunomodulatory effect of gemcitabine was evaluated in blood from pancreatic cancer patients receiving their first 28-day cycle of treatment with infusions day 1, 8 and 15 followed by a resting period. Gemcitabine reduced the level of immunosup-pressive cells and molecules but the effect did not last throughout the resting period. On the other hand, gemcitabine did not affect the level or proliferative function of effector T cells indicating that gemcitabine could be combined with immunotherapy. The LOAd700 virus expresses a novel membrane-bound trimerized form of CD40L (TMZ-CD40L). In paper II, LOAd700 showed to be oncolytic in pancreatic cancer cell lines as well as being immunostimulatory as shown by its capacity to activate dendritic cells (DCs), myeloid cells, endothelium, and to promote expansion of antigen-specific T cells. In paper III, LOAd703 armed with both 4-1BBL and TMZ-CD40L was evaluated. LOAd703 gave a more profound effect than LOAd700 on activation of DCs and the virus was also capable of reducing factors in stellate cells connected to the desmo-plastic and immunosuppressive microenvironment. In paper IV, LOAd713 armed with TMZ-CD40L in combination with a single-chain variable fragment against IL-6R was evaluated. The virus could kill pancreatic cancer cells lines through oncolysis and could also reduce factors involved in desmoplasia in stellate cells. Most interestingly, LOAd713 could reduce the up-regulation of PD-1/PD-L1 in DCs after CD40 activation. Taken together, LOAd703 and LOAd713 seem to have interesting features with their combination of immunostimulation and microenvironment modulation. At present, LOAd703 is evaluated in a clinical trial for pancreatic cancer (NCT02705196). |
| 英文关键词 | Pancreatic cancer Immunotherapy Oncolytic viruses Adenoviruses CD40L 4-1BBL IL-6 Tumor microenvironment Cancer and Oncology Cancer och onkologi Immunology in the medical area Immunologi inom det medicinska omr?det |
| 语种 | 英语 |
| URL | http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-330189 |
| 来源机构 | Uppsala University |
| 资源类型 | 学位论文 |
| 条目标识符 | http://119.78.100.177/qdio/handle/2XILL650/250688 |
| 推荐引用方式 GB/T 7714 | Eriksson;Emma. Preclinical evaluation of immunostimulatory gene therapy for pancreatic cancer[D]. Uppsala universitet, Institutionen för immunologi, genetik och patologi, Uppsala,2017. |
| 条目包含的文件 | 条目无相关文件。 | |||||
| 个性服务 |
| 推荐该条目 |
| 保存到收藏夹 |
| 导出为Endnote文件 |
| 谷歌学术 |
| 谷歌学术中相似的文章 |
| [Eriksson;Emma]的文章 |
| 百度学术 |
| 百度学术中相似的文章 |
| [Eriksson;Emma]的文章 |
| 必应学术 |
| 必应学术中相似的文章 |
| [Eriksson;Emma]的文章 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
